References
- DeMaria T F, Prior R B, Briggs B R, et al. Endotoxin in middle ear effusions from patients with chronic otitis media with Effusion. J Clin Microbiol 1984; 20: 15–7
- Iino Y, Keneko Y, Takasaka T. Endotoxin in middle ear effusions tested with limulus assay. Acta Otolaryngol (Stockh) 1985; 100: 42–50
- Nonomura N, Nakano Y, Satoh Y, et al. Otitis media with effusion following innoculation of Haemophilus influenzae type b endotoxin. Arch Otorhinolaryngol 1986; 243: 31–5
- DeMaria T F, Yamaguchi T, Lim DJ. Quantitative cytologic and histologic changes in the middle ear after the injection of nontypable Haemophilus influenzae endotoxin. Am J Otolaryngol 1989; 10: 261–6
- Kawauchi H, De Maria T F, Lim DJ. Endotoxin permeability through the round window. Acta Otolaryngol (Stockh) 1988; 100–15, Suppl 457
- Rietsche ET, Brade H. Bacterial endotoxins. Sci Am August, 1992; 54–61
- Hitchcock P J, Leive L, Makela P H, et al. Lipopolysac-charide nomenclature-past, present, and future. J Bac-teriol 1986; 166: 699–705
- Lebel MH. Dexamethasone therapy of bacterial meningitis. Antibiot Chemother 1992; 45: 169–83
- Mattsby-Baltzer I, Lindgren K, Lindholm B, Edebo L. Endotoxin shedding by enterobacteria: free and cell-bound endotoxin differ in limulus activity. Infect Immun 1991; 59: 689–95
- Mustafa M M, Ramilo O, Mertsola J, et al. Modulation of inflammation and cachectin activity in relation to treatment of experimental Haemophilus influenzae type b meningitis. J Infect Dis 1989; 160: 818–25
- Dofferhoff A SM, Nijland J H, de Vries-Hospers H G, Mulder P OM, Weits J, Bom V JJ. Effects of different types and combinations of antimicrobial agents on endotoxin release from gram-negative bacteria: an in vitro and in vivo study. Scand J Infect Dis 1991; 23: 745–54
- Hurley J C, Louis W J, Tosolini F A, Carlin JB. Antibiotic-induced release of endotoxin in chronically bacteri-uric patients. Antimicrob Agents Chemother 1991; 35: 2388–94
- Shenep J L, Barton R P, Mogan KA. Role of antibiotic class in the rate of liberation of endotoxin during therapy for experimental Gram-negative bacterial sepsis. J Infect Dis 1985; 151: 1012–8
- Walterspiel J W, Kaplan S L, Mason EO. Protective effect of subinhibititory polymixin B alone and in combination with ampicillin for overwhelming Haemophilus influenzae type b infection in the infant rat: evidence for in vivo and in vitro release of free endotoxin after ampicillin treatment. Pediatr Res 1986; 3: 237–41
- Rokke O, Revhaug A, Osterud B, Giercksky KE. Increased plasma levels of endotoxin and corresponding changes in circulatory performance in a porcine sepsis model: the effect of antibiotic administration. Prog Clin Biol Res 1988; 272: 247–62
- Suzuki K, Bakaletz LO. Synergistic effect of adenovirus type 1 and nontypable Haemophilus influenzae in a chinchilla model experimental otitis media. Infect Immun 1994; 62: 1710–8
- Sirakova T, Kolattukudy P E, Murwin D, et al. Role of fimbriae expressed by nontypeable Haemophilus influenzae in pathogenesis of and protection against otitis media and relatedness of the fimbrin subunit to outer membrane protein A. Infect Immun 1994; 62: 2002–20
- Hurley JC. Antibiotic-induced release of endotoxin: a reappraisal. Clin Infect Dis 1992; 15: 840–54
- DeMaria TF. Localization of nontypeable Haemophilus influenzae endotoxin in the middle and inner ear during experimental acute otitis media. Acta Otolaryngol (Stockh) 1997, in press
- DeMaria T F, McPherson C, Bakaletz L O, Holmes KA. Isotope specific antibody response against OMP's and fimbriae of nontypable Haemophilus influenzae isolated from patients with chornic otitis media. Fifth Int. Symp. Recent Advances in Otitis Media 1991; 134: 119, abstr.
- Emancipator K, Csako G, Elin RJ. In vitro inactiva-tion of bacterial endotoxin by human lipoproteins and apolipoproteins. Infect Immun 1992; 60: 596–601